UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

JNK inhibitor and ferroptosis modulator as possible therapeutic modalities in Alzheimer disease (AD)

Scientific reports, 2024-10, Vol.14 (1), p.23293-14, Article 23293

2024

Volltextzugriff (PDF)

Modulating the Siah2-PHD3-HIF1α axis and/or autophagy potentially retard colon cancer proliferation possibly, due to the damping of colon cancer stem cells

Biomedicine & pharmacotherapy, 2022-10, Vol.154, p.113562-113562, Article 113562

2022

Volltextzugriff (PDF)

Perindopril sensitizes hepatocellular carcinoma to chemotherapy: A possible role of leptin / Wnt/ β-catenin axis with subsequent inhibition of liver cancer stem cells

Saudi pharmaceutical journal, 2022-08, Vol.30 (8), p.1170-1180

2022

Volltextzugriff (PDF)

Formulation and assessment of hydroxyzine HCL solid lipid nanoparticles by dual emulsification technique for transdermal delivery

Biomedicine & pharmacotherapy, 2021-11, Vol.143, p.112130, Article 112130

2021

Volltextzugriff (PDF)

Tissue Inhibitor Of Metalloproteinase 3 As A Potential Staging Biomarker In Hepatocellular Carcinoma

Journal of the Pakistan Medical Association, 2023-04, Vol.73(Suppl 4) (4), p.S47-S51

2023

Volltextzugriff (PDF)

Daclatasvir and Sofosbuvir Mitigate Hepatic Fibrosis Through Downregulation of TNF-α / NF-κB Signaling Pathway

Current molecular pharmacology, 2020, Vol.13 (4), p.318-327

2020

Volltextzugriff (PDF)

Targeting the HIF-1α/Cav-1 Pathway with a Chicory Extract/Daidzein Combination Plays a Potential Role in Retarding Hepatocellular Carcinoma

Current cancer drug targets, 2021-01, Vol.21 (10), p.881-896

2021

Volltextzugriff (PDF)

The expression of tuftelin 1 as a new theranostic marker in early diagnosis and as a therapeutic target in hepatocellular carcinoma

Cell biochemistry and function, 2023-10, Vol.41 (7), p.788-800

2023

Volltextzugriff (PDF)

Daidzein and Chicory Extract Arrest the Cell Cycle via Inhibition of Cyclin D/CDK4 and Cyclin A/CDK2 Gene Expression in Hepatocellular Carcinoma

Recent patents on anti-cancer drug discovery, 2023-05, Vol.18 (2), p.187-199

2023

Volltextzugriff (PDF)

Dantrolene Potentiates the Antineoplastic Effect of Sorafenib in Hepatocellular Carcinoma via Targeting Ca +2 /PI3K Signaling Pathway

Current molecular pharmacology, 2021-01, Vol.14 (5), p.900-913

2021

Volltextzugriff (PDF)

Overview of the Molecular Modalities and Signaling Pathways Intersecting with β-Amyloid and Tau Protein in Alzheimer’s Disease

Neuroglia (Basel, Switzerland), 2023-07, Vol.4 (3), p.191-208

2023

Volltextzugriff (PDF)

Dantrolene and coenzyme Q10 as a suggested combination therapy to statin-induced myopathy in high fat diet rats: A possible interference with ROS/ TGF-β / Smad4 signaling pathway

Toxicology and applied pharmacology, 2024-04, Vol.485, p.116900-116900, Article 116900

2024

Volltextzugriff (PDF)

Chemopreventive and antitumor effects of benzyl isothiocynate on HCC models: A possible role of HGF /pAkt/ STAT3 axis and VEGF

Biomedicine & pharmacotherapy, 2018-12, Vol.108, p.65-75

2018

Volltextzugriff (PDF)

Short and Long Term Cardiotoxicity of Sofosbuvir and Daclatasvir Associated With Lipid Profile Abnormalities

Bulletin of pharmaceutical sciences, 2022-11

2022

Volltextzugriff (PDF)

ENHANCEMENT OF DISSOLUTION CHARACTERISTICS OF CLOPIDOGREL BISULPHATE BY PRONIOSOMES

International journal of applied pharmaceutics, 2019-03, p.77-85

2019

Volltextzugriff (PDF)

Dual regulating of mitochondrial fusion and Timp-3 by leflunomide and diallyl disulfide combination suppresses diethylnitrosamine-induced hepatocellular tumorigenesis in rats

Life sciences (1973), 2022-04, Vol.294, p.120369-120369, Article 120369

2022

Volltextzugriff (PDF)

Siah2 Inhibitor and the Metabolic Antagonist Oxamate Retard Colon Cancer Progression and Downregulate PD1 Expression

Recent patents on anti-cancer drug discovery, 2024-02, Vol.19 (1), p.80-92

2024

Volltextzugriff (PDF)

Assessment of YME1L and mitofusin2 as a possible diagnostic and/or therapeutic target in hepatocellular carcinoma

Indian journal of biochemistry & biophysics, 2023

2023

Volltextzugriff (PDF)

Rebamipide retards CCl4-induced hepatic fibrosis in rats: Possible role for PGE2

Journal of immunotoxicology, 2016-07, Vol.13 (4), p.453-462

2016

Volltextzugriff (PDF)

OMA1 and YME1L as a Diagnostic Panel in Hepatocellular Carcinoma

The Yale journal of biology & medicine, 2023-12, Vol.96 (4), p.443-454

2023

Volltextzugriff (PDF)

Rebamipide retards CCl 4 -induced hepatic fibrosis in rats: Possible role for PGE 2

Journal of immunotoxicology, 2016-07, Vol.13 (4), p.453-462

2016

Volltextzugriff (PDF)

SHORT AND LONG TERM CARDIOTOXICITY OF SOFOSBUVIR AND DACLATASVIR ASSOCIATED WITH LIPID PROFILE ABNORMALITIES

Bulletin of pharmaceutical sciences, 2023-06, Vol.46 (1), p.551-563

2023

Volltextzugriff (PDF)

Potential Anti-Fibrotic Effect of Direct Acting Antiviral Drugs on CCl4 Induced Hepatic Fibrosis in Rats

Egyptian Journal of Basic and Clinical Pharmacology, 2019, Vol.9

2019

Volltextzugriff (PDF)

Randomized placebo-controlled study of baclofen in the treatment of muscle cramps in patients with liver cirrhosis

European journal of gastroenterology & hepatology, 2016-11, Vol.28 (11), p.1280-1284

2016

Volltextzugriff (PDF)

Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open‐angle glaucoma in rabbits

Journal of pharmacy and pharmacology, 2020-05, Vol.72 (5), p.682-698

2020

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(37)
Bücher
(1)

Sprache

Englisch
(35)
Arabisch
(3)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

JNK inhibitor and ferroptosis modulator as possible therapeutic modalities in Alzheimer disease (AD)

Modulating the Siah2-PHD3-HIF1α axis and/or autophagy potentially retard colon cancer proliferation possibly, due to the damping of colon cancer stem cells

Perindopril sensitizes hepatocellular carcinoma to chemotherapy: A possible role of leptin / Wnt/ β-catenin axis with subsequent inhibition of liver cancer stem cells

Formulation and assessment of hydroxyzine HCL solid lipid nanoparticles by dual emulsification technique for transdermal delivery

Tissue Inhibitor Of Metalloproteinase 3 As A Potential Staging Biomarker In Hepatocellular Carcinoma

Daclatasvir and Sofosbuvir Mitigate Hepatic Fibrosis Through Downregulation of TNF-α / NF-κB Signaling Pathway

Targeting the HIF-1α/Cav-1 Pathway with a Chicory Extract/Daidzein Combination Plays a Potential Role in Retarding Hepatocellular Carcinoma

The expression of tuftelin 1 as a new theranostic marker in early diagnosis and as a therapeutic target in hepatocellular carcinoma

Daidzein and Chicory Extract Arrest the Cell Cycle via Inhibition of Cyclin D/CDK4 and Cyclin A/CDK2 Gene Expression in Hepatocellular Carcinoma

Dantrolene Potentiates the Antineoplastic Effect of Sorafenib in Hepatocellular Carcinoma via Targeting Ca +2 /PI3K Signaling Pathway

Overview of the Molecular Modalities and Signaling Pathways Intersecting with β-Amyloid and Tau Protein in Alzheimer’s Disease

Dantrolene and coenzyme Q10 as a suggested combination therapy to statin-induced myopathy in high fat diet rats: A possible interference with ROS/ TGF-β / Smad4 signaling pathway

Chemopreventive and antitumor effects of benzyl isothiocynate on HCC models: A possible role of HGF /pAkt/ STAT3 axis and VEGF

Short and Long Term Cardiotoxicity of Sofosbuvir and Daclatasvir Associated With Lipid Profile Abnormalities

ENHANCEMENT OF DISSOLUTION CHARACTERISTICS OF CLOPIDOGREL BISULPHATE BY PRONIOSOMES

Dual regulating of mitochondrial fusion and Timp-3 by leflunomide and diallyl disulfide combination suppresses diethylnitrosamine-induced hepatocellular tumorigenesis in rats

Siah2 Inhibitor and the Metabolic Antagonist Oxamate Retard Colon Cancer Progression and Downregulate PD1 Expression

Assessment of YME1L and mitofusin2 as a possible diagnostic and/or therapeutic target in hepatocellular carcinoma

Rebamipide retards CCl4-induced hepatic fibrosis in rats: Possible role for PGE2

OMA1 and YME1L as a Diagnostic Panel in Hepatocellular Carcinoma

Rebamipide retards CCl 4 -induced hepatic fibrosis in rats: Possible role for PGE 2

SHORT AND LONG TERM CARDIOTOXICITY OF SOFOSBUVIR AND DACLATASVIR ASSOCIATED WITH LIPID PROFILE ABNORMALITIES

Potential Anti-Fibrotic Effect of Direct Acting Antiviral Drugs on CCl4 Induced Hepatic Fibrosis in Rats

Randomized placebo-controlled study of baclofen in the treatment of muscle cramps in patients with liver cirrhosis

Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open‐angle glaucoma in rabbits

Suchergebnisse filtern